TCM Sailuotong to be trialed in vascular dementia

Complementary Medicines Australia has welcomed the announcement by the National Institute of Complementary Medicine of a clinical trial for a Chinese herbal medicine, Sailuotong. Sailuotong has been shown, in pilot studies, to be effective in improving the cognitive and memory impairment associated with vascular dementia. “This is promising news for the large number of Australians

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists critical in meds supply during bushfires and other disasters
Next DDS donates $11,000+ to McGrath Foundation